1 reports of this reaction
3.1% of all POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL reports
#20 most reported adverse reaction
UVEITIS is the #20 most commonly reported adverse reaction for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL, manufactured by Wal-Mart Stores, Inc.. There are 1 FDA adverse event reports linking POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL to UVEITIS. This represents approximately 3.1% of all 32 adverse event reports for this drug.
Patients taking POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL who experience uveitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
UVEITIS is moderately reported among POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL users, representing a notable but not dominant share of adverse events.
In addition to uveitis, the following adverse reactions have been reported for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL:
The following drugs have also been linked to uveitis in FDA adverse event reports:
UVEITIS has been reported as an adverse event in 1 FDA reports for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
UVEITIS accounts for approximately 3.1% of all adverse event reports for POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL, making it a notable side effect.
If you experience uveitis while taking POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.